TGFB1 and systemic sclerosis: We also show that SSc fibroblasts have decreased levels of PP2A and that this could be restored by blockade of autocrine TGFβ signaling, suggesting that negative regulation of the PP2A catalytic subunit gene expression may be a physiological mechanism by which sustained ERK1/2 phosphorylation occurs in SSc.